| Abstract: |
Discusses the development of psychooncology, which addresses the psychological (psychosocial) responses to cancer of patients, families, and caretakers at all stages of disease and the psychological, behavioral, and social (psychobiological) factors that influence risk, detection, and survival. The recent development of a unitary measure that combines length of survival and quality of life may be helpful in weighing the outcome of different primary treatment options. Also addressed is the possible interaction of psychological, endocrine, and immune function variables in cancer morbidity and mortality. Findings may show that interventions based on psychophysiological interactions can have salutary effects on cancer treatment. Patients' responses to holistic programs and coping styles are also discussed. (PsycINFO Database Record (c) 2016 APA, all rights reserved) |
